查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1446562

生命科学 MES（製造执行系统）市场规模、份额、趋势分析报告：按解决方案类型、部署、最终用户、地区和细分市场预测，2024-2030 年

Manufacturing Execution System in Life Sciences Market Size, Share & Trends Analysis Report By Solution Type, By Deployment (On-Premise, Cloud/Web-Based, Hybrid), By End-User, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

生命科学的 MES（製造执行系统）市场成长与趋势：

Grand View Research, Inc. 的最新报告显示，生命科学 MES 的全球市场规模预计到 2030 年将达到 60 亿美元，2024 年至 2030 年复合年增长率为 12.2%。

MES 的实施已成为生命科学产业的关键要素，有助于提高整个生产过程的效率、合规性和创新性。在北美，MES 在生命科学领域的采用正在迅速增加，凸显了其对製造工作流程的变革性影响。製药和生物技术等生命科学产业需要复杂的製造管理方法。 MES 提供整合的、资料主导的解决方案，在满足和超越监管要求、降低风险和确保产品品质方面发挥关键作用。

生命科学製造对精度和品质的需求不断增长是市场成长的关键驱动力。 MES 可让您优化製造工作流程、最大限度地减少错误并保持产品开发的一致性。随着业界转向个人化医疗和创新治疗方法，MES 的弹性和敏捷性尤其有价值。此外，工业 4.0 技术的兴起正在推动 MES 的采用。与物联网 (IoT) 和分析的集合成为生命科学製造商创建了智慧製造生态系统。这种连接可以实现即时监控、控制和资料主导的决策，从而提高业务效率。对生产力、缩短时间和卓越的产品品质日益增长的需求正在推动 MES 在生命科学产业的采用。 MES 正在成为现代製造业追求无缝、互联和技术先进的未来的中心枢纽。

生命科学 MES 市场报告亮点

  • 由于对无纸化製造的高需求、製造流程向数位化和自动化的转变，软体解决方案类型细分市场在 2023 年占据最大份额。
  • 预计本地部署细分市场将在 2023 年占据最大份额，并在 2024 年至 2030 年期间以 11.7% 的复合年增长率成长。本地MES系统易于在本地储存资料，且不依赖繁重的互联网来不间断通讯。
  • 这些因素正在推动市场的采用。同时，基于云端/网路的部署领域预计将从 2024 年到 2030 年以 13.0% 的复合年增长率增长最快。
  • 2023年，製药和生技公司的最终用户部分占最大份额，达到48.4%。这可以归因于自动化和数数位化趋势导致该领域 MES 的高采用率。
  • 由于艾默生电气公司、罗克韦尔自动化和西门子公司等主要参与者的存在，北美在 2023 年以 31.0% 的份额主导全球市场。预计 2024 年至 2030 年，亚太地区将以最快的复合年增长率成长。
  • 主要参与者正在采取产品开发、合作、併购等各种策略，这正在推动市场竞争。
  • 例如，2023 年 9 月，Korber 和 Endeavor 合作促进 Werum PAS-X MES 与 SAP ERP 平台的整合。此次合作旨在为使用这两种软体解决方案进行业务的企业提供无缝解决方案。

目录

第一章调查方法和范围

第 2 章执行摘要

第 3 章生命科学 MES 市场：变数、趋势、范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 生命科学 MES 市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章生命科学MES市场：解决方案类型的估算与趋势分析

  • 定义和范围
  • 细分仪表板
  • 生命科学MES市场波动分析
  • 2018-2030 年生命科学 MES 市场规模和趋势分析（按解决方案类型）

第五章生命科学MES市场：发展预估与趋势分析

  • 定义和范围
  • 细分仪表板
  • 生命科学MES市场波动分析
  • 2018-2030 年生命科学 MES 市场规模与趋势分析（按部署）

第六章生命科学MES市场：最终用户估计与趋势分析

  • 定义和范围
  • 细分仪表板
  • 生命科学MES市场波动分析
  • 2018-2030 年生命科学 MES 市场规模与趋势分析（按最终用户）

第 7 章生命科学 MES 市场：按解决方案类型、部署和最终用户分類的区域估计和趋势分析

  • 区域市场仪表板
  • 全球区域市场概述
  • 2018-2030年市场规模及预测趋势分析
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第八章 竞争形势

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争对手分类
    • 创新者
  • 供应商形势
    • ABB
    • Korber AG
    • MasterControl Solutions, Inc.
    • AVEVA Group Limited
    • Cognizant
    • Rockwell Automation
    • nagarro
    • Siemens AG
    • Emerson Electric Co.
    • iBase-t
Product Code: GVR-4-68040-206-3

Manufacturing Execution System in Life Sciences Market Growth & Trends:

The global manufacturing execution system in life sciences market size is anticipated to reach USD 6.0 billion by 2030, registering a CAGR of 12.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. The adoption of manufacturing execution system (MES) is emerging as a key factor in the life science industry, helping to improve efficiency, compliance, and innovation across production processes. In North America, MES implementation is experiencing a significant surge in the life science sector, highlighting its transformative impact on manufacturing workflows. Life science industries, including pharmaceuticals and biotechnology, require a sophisticated approach to manufacturing management. MES provides integrated and data-driven solutions that are instrumental in meeting and exceeding regulatory requirements, reducing risks, and ensuring product quality.

The growing demand for precision and quality in life science manufacturing is a key driver of market growth. MES enables companies to optimize production workflows, minimize errors, and maintain consistency in product development. Its flexibility and agility are especially valuable as the industry shifts toward personalized medicine and innovative therapies. Moreover, the prominence of Industry 4.0 technologies has bolstered the adoption of MES. Integration with the Internet of Things (IoT) and analytics creates an intelligent manufacturing ecosystem for life science manufacturers. This connectivity enables real-time monitoring, control, and data-driven decision-making, enhancing operational efficiency. Increasing demand for productivity, faster time-to-market, and superior product quality boost the adoption of MES in the life science industry. MES is becoming a central hub in the pursuit of a seamless, interconnected, and technologically advanced future in modern manufacturing.

Manufacturing Execution System in Life Sciences Market Report Highlights:

  • The software solution type segment held the largest share in 2023 due to the high demand for paperless manufacturing, shift towards digitalization, and automation in manufacturing processes
  • The on-premise deployment segment held the largest share in 2023 and is expected to grow at a CAGR of 11.7% from 2024 to 2030. The on-premise MES system offers ease of storing data on premises and does not rely on heavy internet, which will not hamper communication
  • Such factors drive its adoption in the market. On the other hand, the cloud/web-based deployment segment is expected to grow at the fastest CAGR of 13.0% from 2024 to 2030
  • The pharmaceutical & biotechnology companies end-use segment held the largest share of 48.4% in 2023. This can be attributed to the high adoption of MES in this segment owing to the shifting trend towards automation and digitalization
  • North America dominated the global market with a share of 31.0% in 2023 owing to the presence of key players including Emerson Electric Co., Rockwell Automation, and Siemens AG. Asia Pacific is expected to grow at the fastest CAGR from 2024 to 2030
  • Various strategies, such as product development, partnerships, and mergers & acquisitions, are adopted by key players, which is driving the market competition
  • For instance, in September 2023, Korber and Endeavor partnered to facilitate the integration of Werum PAS-X MES with SAP's ERP platform. This partnership aims to provide a seamless solution for businesses that use these two software solutions for their operations

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
      • 1.3.5.1. Data for primary interviews in North America
      • 1.3.5.2. Data for primary interviews in Europe
      • 1.3.5.3. Data for primary interviews in Asia Pacific
      • 1.3.5.4. Data for primary interviews in Latin America
      • 1.3.5.5. Data for Primary interviews in MEA
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Data Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Solution Type outlook
    • 2.2.2. Deployment outlook
    • 2.2.3. End-User outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Manufacturing Execution System in Life Sciences Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Growing demand for personalized medicine
      • 3.2.1.2. Growth in pharmaceutical and biotechnology sector
      • 3.2.1.3. Technological advancements
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High implementation costs and complexity
  • 3.3. Manufacturing Execution System in Life Sciences Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Manufacturing Execution System in Life Sciences Market: Solution Type Estimates & Trend Analysis

  • 4.1. Definitions and Scope
  • 4.2. Segment Dashboard
  • 4.3. Manufacturing Execution System in Life Sciences Market Movement Analysis
  • 4.4. Manufacturing Execution System in Life Sciences Market Size & Trend Analysis, by Solution Type, 2018 to 2030 (USD Million)
    • 4.4.1. Software
      • 4.4.1.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 4.4.2. Services
      • 4.4.2.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Manufacturing Execution System in Life Sciences Market: Deployment Estimates & Trend Analysis

  • 5.1. Definitions and Scope
  • 5.2. Segment Dashboard
  • 5.3. Manufacturing Execution System in Life Sciences Market Movement Analysis
  • 5.4. Manufacturing Execution System in Life Sciences Market Size & Trend Analyses, by Deployment, 2018 to 2030 (USD Million)
    • 5.4.1. On-Premise
      • 5.4.1.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 5.4.2. Cloud/Web-based
      • 5.4.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 5.4.3. Hybrid
      • 5.4.3.1. Hybrid market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Manufacturing Execution System in Life Sciences Market: End-user Estimates & Trend Analysis

  • 6.1. Definitions and Scope
  • 6.2. Segment Dashboard
  • 6.3. Manufacturing Execution System in Life Sciences Market Movement Analysis
  • 6.4. Manufacturing Execution System in Life Sciences Market Size & Trend Analyses, by End-User, 2018 to 2030 (USD Million)
    • 6.4.1. Pharmaceutical and Biotechnology Companies
      • 6.4.1.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 6.4.2. Medical Device Companies
      • 6.4.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 6.4.3. Others (CDMOs, CROs, etc.)
      • 6.4.3.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Manufacturing Execution System in Life Sciences Market: Regional Estimates & Trend Analysis by Solution Type, Deployment, & End-User

  • 7.1. Regional Market Dashboard
  • 7.2. Global Regional Market Snapshot
  • 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030
  • 7.4. North America
    • 7.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. U.S. country dynamics
      • 7.4.2.2. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Canada country dynamics
      • 7.4.3.2. Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. UK country dynamics
      • 7.5.2.2. UK market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Germany country dynamics
      • 7.5.3.2. Germany market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. France country dynamics
      • 7.5.4.2. France market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Italy country dynamics
      • 7.5.5.2. Italy market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Spain country dynamics
      • 7.5.6.2. Spain market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.5.7. Norway
      • 7.5.7.1. Norway country dynamics
      • 7.5.7.2. Norway market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.5.8. Sweden
      • 7.5.8.1. Sweden
      • 7.5.8.2. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.5.9. Denmark
      • 7.5.9.1. Denmark
      • 7.5.9.2. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Japan country dynamics
      • 7.6.2.2. Japan market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. China country dynamics
      • 7.6.3.2. China market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. India country dynamics
      • 7.6.4.2. India market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.5. Australia
      • 7.6.5.1. Australia country dynamics
      • 7.6.5.2. Australia market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.6. South Korea
      • 7.6.6.1. South Korea
      • 7.6.6.2. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Thailand
      • 7.6.7.2. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Brazil
      • 7.7.2.2. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.7.3. Mexico
      • 7.7.3.1. Mexico
      • 7.7.3.2. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.7.4. Argentina
      • 7.7.4.1. Argentina country dynamics
      • 7.7.4.2. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. South Africa country dynamics
      • 7.8.2.2. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Saudi Arabia country dynamics
      • 7.8.3.2. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. UAE country dynamics
      • 7.8.4.2. UAE market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Kuwait country dynamics
      • 7.8.5.2. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
    • 8.2.1. Innovators
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2023
    • 8.3.4. ABB
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Korber AG
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. MasterControl Solutions, Inc.
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. AVEVA Group Limited
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Cognizant
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Rockwell Automation
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. nagarro
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Siemens AG
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. Emerson Electric Co.
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Product benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13. iBase-t
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. Product benchmarking
      • 8.3.13.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America MES in life sciences market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
  • Table 4 North America MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
  • Table 5 North America MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
  • Table 6 U.S. MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
  • Table 7 U.S. MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
  • Table 8 U.S. MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
  • Table 9 Canada MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
  • Table 10 Canada MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
  • Table 11 Canada MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
  • Table 12 Europe MES in life sciences market, by region, 2018 - 2030 (USD Million)
  • Table 13 Europe MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
  • Table 14 Europe MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
  • Table 15 Europe MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
  • Table 16 Germany MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
  • Table 17 Germany MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
  • Table 18 Germany MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
  • Table 19 UK MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
  • Table 20 UK MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
  • Table 21 UK MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
  • Table 22 France MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
  • Table 23 France MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
  • Table 24 France MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
  • Table 25 Italy MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
  • Table 26 Italy MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
  • Table 27 Italy MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
  • Table 28 Spain MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
  • Table 29 Spain MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
  • Table 30 Spain MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
  • Table 31 Denmark MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
  • Table 32 Denmark MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
  • Table 33 Denmark MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
  • Table 34 Sweden MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
  • Table 35 Sweden MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
  • Table 36 Sweden MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
  • Table 37 Norway MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
  • Table 38 Norway MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
  • Table 39 Norway MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific MES in life sciences market, by region, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
  • Table 44 China MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
  • Table 45 China MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
  • Table 46 China MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
  • Table 47 Japan MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
  • Table 48 Japan MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
  • Table 49 Japan MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
  • Table 50 India MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
  • Table 51 India MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
  • Table 52 India MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
  • Table 53 South Korea MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
  • Table 54 South Korea MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
  • Table 55 South Korea MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
  • Table 56 Australia MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
  • Table 57 Australia MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
  • Table 58 Australia MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
  • Table 59 Thailand MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
  • Table 60 Thailand MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
  • Table 61 Thailand MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
  • Table 62 Latin America MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
  • Table 63 Latin America MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
  • Table 64 Latin America MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
  • Table 65 Brazil MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
  • Table 66 Brazil MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
  • Table 67 Brazil MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
  • Table 68 Mexico MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
  • Table 69 Mexico MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
  • Table 70 Mexico MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
  • Table 71 Argentina MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
  • Table 72 Argentina MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
  • Table 73 Argentina surgical ablation market, by end-user, 2018 - 2030 (USD Million)
  • Table 74 MEA MES in life sciences market, by region, 2018 - 2030 (USD Million)
  • Table 75 MEA MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
  • Table 76 MEA MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
  • Table 77 MEA MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
  • Table 78 South Africa MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
  • Table 79 South Africa MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
  • Table 80 South Africa MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
  • Table 81 Saudi Arabia MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
  • Table 84 UAE MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
  • Table 85 UAE MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
  • Table 86 UAE MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
  • Table 87 Kuwait MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
  • Table 88 Kuwait MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
  • Table 89 Kuwait MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
  • Table 90 List of other players
  • Table 91 Participant's overview
  • Table 92 Financial per Deploymentance
  • Table 93 Key companies undergoing expansions
  • Table 94 Key companies undergoing acquisitions
  • Table 95 Key companies undergoing collaborations
  • Table 96 Key companies launching new components/services
  • Table 97 Key companies undergoing partnerships
  • Table 98 Key companies undertaking other strategies

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 MES in life sciences market: market outlook
  • Fig. 10 MES in life sciences competitive insights
  • Fig. 11 Parent market outlook
  • Fig. 12 Related/ancillary market outlook
  • Fig. 13 Penetration and growth prospect mapping
  • Fig. 14 Industry value chain analysis
  • Fig. 15 MES in life sciences market driver impact
  • Fig. 16 MES in life sciences market restraint impact
  • Fig. 17 MES in life sciences market strategic initiatives analysis
  • Fig. 18 MES in life sciences market: Solution Type movement analysis
  • Fig. 19 MES in life sciences market: Solution Type outlook and key takeaways
  • Fig. 20 Software market estimates and forecast, 2018 - 2030
  • Fig. 21 Services estimates and forecast, 2018 - 2030
  • Fig. 22 MES in life sciences market: deployment movement analysis
  • Fig. 23 MES in life sciences market: deployment outlook and key takeaways
  • Fig. 24 On-premise market estimates and forecast, 2018 - 2030
  • Fig. 25 Clou/Web-based market estimates and forecast,2018 - 2030
  • Fig. 26 Hybrid market estimates and forecast,2018 - 2030
  • Fig. 27 MES in life sciences market: end-user movement analysis
  • Fig. 28 MES in life sciences market: end-user outlook and key takeaways
  • Fig. 29 Pharmaceutical and biotechnology companies market estimates and forecast, 2018 - 2030
  • Fig. 30 Medical Device Companies market estimates and forecast,2018 - 2030
  • Fig. 31 Others market estimates and forecast, 2018 - 2030
  • Fig. 32 Global MES in life sciences market: regional movement analysis
  • Fig. 33 Global MES in life sciences market: regional outlook and key takeaways
  • Fig. 34 Global MES in life sciences market share and leading players
  • Fig. 35 North America market share and leading players
  • Fig. 36 Europe market share and leading players
  • Fig. 37 Asia Pacific market share and leading players
  • Fig. 38 Latin America market share and leading players
  • Fig. 39 Middle East & Africa market share and leading players
  • Fig. 40 North America: SWOT
  • Fig. 41 Europe SWOT
  • Fig. 42 Asia Pacific SWOT
  • Fig. 43 Latin America SWOT
  • Fig. 44 MEA SWOT
  • Fig. 45 North America, by country
  • Fig. 46 North America market estimates and forecast, 2018 - 2030
  • Fig. 47 U.S. market estimates and forecast, 2018 - 2030
  • Fig. 48 Canada market estimates and forecast, 2018 - 2030
  • Fig. 49 Europe market estimates and forecast, 2018 - 2030
  • Fig. 50 UK market estimates and forecast, 2018 - 2030
  • Fig. 51 Germany market estimates and forecast, 2018 - 2030
  • Fig. 52 France market estimates and forecast, 2018 - 2030
  • Fig. 53 Italy market estimates and forecast, 2018 - 2030
  • Fig. 54 Spain market estimates and forecast, 2018 - 2030
  • Fig. 55 Denmark market estimates and forecast, 2018 - 2030
  • Fig. 56 Sweden market estimates and forecast, 2018 - 2030
  • Fig. 57 Norway market estimates and forecast, 2018 - 2030
  • Fig. 58 Asia Pacific market estimates and forecast, 2018 - 2030
  • Fig. 59 China market estimates and forecast, 2018 - 2030
  • Fig. 60 Japan market estimates and forecast, 2018 - 2030
  • Fig. 61 India market estimates and forecast, 2018 - 2030
  • Fig. 62 Thailand market estimates and forecast, 2018 - 2030
  • Fig. 63 South Korea market estimates and forecast, 2018 - 2030
  • Fig. 64 Australia market estimates and forecast, 2018 - 2030
  • Fig. 65 Latin America market estimates and forecast, 2018 - 2030
  • Fig. 66 Brazil market estimates and forecast, 2018 - 2030
  • Fig. 67 Mexico market estimates and forecast, 2018 - 2030
  • Fig. 68 Argentina market estimates and forecast, 2018 - 2030
  • Fig. 69 Middle East and Africa market estimates and forecast, 2018 - 2030
  • Fig. 70 South Africa market estimates and forecast, 2018 - 2030
  • Fig. 71 Saudi Arabia market estimates and forecast, 2018 - 2030
  • Fig. 72 UAE market estimates and forecast, 2018 - 2030
  • Fig. 73 Kuwait market estimates and forecast, 2018 - 2030
  • Fig. 74 Market share of key market players - MES in life sciences market